Inactive Instrument

Press Releases Kindred Biosciences, Inc.

Equities

KIN

US4945771099

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Kindred Biosciences : Market Offering Agreement (Form 8-K)	30/08/21	PU
KINDRED BIOSCIENCES, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	30/08/21	AQ
KINDRED BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	26/08/21	AQ
Kindred Bio: Q2 Earnings Snapshot	06/08/21	AQ
KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	05/08/21	AQ
KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	02/08/21	AQ
KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	01/07/21	AQ
KINDRED BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	24/06/21	AQ
KINDRED BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Biosciences, Inc. - KIN	21/06/21	BU
Kindred Biosciences : FORM OF SUPPORT AGREEMENT (Form 8-K)	16/06/21	PU
KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	16/06/21	AQ
Kindred Biosciences : Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus	03/06/21	AQ
Kindred Biosciences : Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus (Form 8-K)	02/06/21	PU
KINDRED BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	02/06/21	AQ
Kindred Biosciences : to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI	25/05/21	PR
Kindred Bio: Q1 Earnings Snapshot	11/05/21	AQ
KINDRED BIOSCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	11/05/21	AQ
KINDRED BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K)	11/05/21	AQ
Kindred Biosciences : Announces First Quarter 2021 Financial Results	11/05/21	PR
Kindred Biosciences : Announces First Quarter 2021 Financial Results (Form 8-K)	10/05/21	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kindred Biosciences, Inc.

Equities

KIN

US4945771099

Press Releases

Filters